Article: Ventana Medical Systems Files Patent Litigation against Vision in United States Federal Court.

TUCSON, Ariz. -- Ventana Medical Systems, Inc. (NASDAQ: VMSI) today announced that it commenced patent litigation to protect its intellectual property against Vision BioSystems Inc., a subsidiary of Vision Systems Limited (ASX: VSL). The suit was filed in United States District Court for the District of Massachusetts on September 18, 2006.

In its Complaint, Ventana alleges that Vision's Bond(TM) X and maX OCR instruments infringe its U.S. Patent No. 6,594,537 for schedule optimization, or more specifically, scheduling algorithms which enable optimal sequencing of multiple tests. The Complaint seeks injunctive relief and damages. Ventana had previously obtained a ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!